Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Santarone, Stella
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Arora M
,
Hemmer MT
,
Ahn KWoo
,
Klein JP
,
Cutler CS
,
Urbano-Ispizua A
,
Couriel DR
,
Alousi AM
,
Gale RPeter
,
Inamoto Y
, et al.
CIBMTR Chronic GVHD Risk Score Predicts Mortality in an Independent Validation Cohort.
Biol Blood Marrow Transplant. 2014.
PubMed
Google Scholar
I
Santoro N
,
Labopin M
,
Ciceri F
,
van Lint MTeresa
,
Nasso D
,
Blaise D
,
Arcese W
,
Tischer J
,
Bruno B
,
Ehninger G
, et al.
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age.
Cancer. 2019.
PubMed
Google Scholar
Musso M
,
Messina G
,
Di Renzo N
,
Di Carlo P
,
Vitolo U
,
Scalone R
,
Marcacci G
,
Scalzulli PR
,
Moscato T
,
Matera R
, et al.
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Br J Haematol. 2015.
PubMed
Google Scholar
O
Candoni A
,
Rambaldi A
,
Fanin R
,
Velardi A
,
Arcese W
,
Ciceri F
,
Lazzarotto D
,
Lussana F
,
Olivieri J
,
Grillo G
, et al.
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Societ
. Biol Blood Marrow Transplant. 2019.
PubMed
Google Scholar
S
Nagler A
,
Labopin M
,
Dholaria B
,
Finke J
,
Brecht A
,
Schanz U
,
Niittyvuopio R
,
Neubauer A
,
Bornhäuser M
,
Santarone S
, et al.
Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation.
Br J Haematol. 2019.
PubMed
Google Scholar
Falconi G
,
Fabiani E
,
Piciocchi A
,
Criscuolo M
,
Fianchi L
,
Rossi ELLindfors
,
Finelli C
,
Cerqui E
,
Ottone T
,
Molteni A
, et al.
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.
Leukemia. 2018.
PubMed
Google Scholar